Cargando…

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis

BACKGROUND AND PURPOSE: Sarcopenia is highly prevalent (28.5–40.3%) in patients undergoing hemodialysis and leads to poor clinical outcomes. However, the association between muscle quality and sarcopenia in patients receiving hemodialysis remains unclear. Therefore, we aimed to explore the associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Chen, Yan, Dong, Wang, Ling, Duan, Fangfang, Gu, Dalong, Yao, Ning, Sun, Mingke, Wang, Di, Lin, Xuya, Wu, Yanglei, Wang, Xiaofei, Cheng, Xiaoguang, Zhang, Dongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076821/ https://www.ncbi.nlm.nih.gov/pubmed/37033264 http://dx.doi.org/10.3389/fendo.2023.1117438

Ejemplares similares

Sarcopenia and osteosarcopenia among patients undergoing hemodialysis
por: Xiang, Ting, et al.
Publicado: (2023)

Associations of Lumber Disc Degeneration With Paraspinal Muscles Myosteatosis in Discogenic Low Back Pain
por: Huang, Yilong, et al.
Publicado: (2022)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
por: Jördens, Markus S., et al.
Publicado: (2021)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
por: Feng, Hongjuan, et al.
Publicado: (2021)

Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults
por: Tan, Lingling, et al.
Publicado: (2021)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures
por: Badr, Sammy, et al.
Publicado: (2023)

Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment
por: Ahern, Elizabeth, et al.
Publicado: (2023)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Sarcopenia and Myosteatosis at Presentation Adversely Affect Survival After Esophagectomy for Esophageal Cancer
por: Srpcic, Matevz, et al.
Publicado: (2020)

Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review
por: Lortie, Jevin, et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
por: Yin, Liang, et al.
Publicado: (2023)

Defining sarcopenia and myosteatosis: the necessity for consensus on a technical standard and standardized cut‐off values
por: Westenberg, Lisa B., et al.
Publicado: (2022)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
por: Chen, Qi, et al.
Publicado: (2022)

Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality
por: Engelmann, Simon U., et al.
Publicado: (2023)

Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
por: West, Malcolm A., et al.
Publicado: (2019)

Cognitive Domain Impairment and All-Cause Mortality in Older Patients Undergoing Hemodialysis
por: Guo, Yidan, et al.
Publicado: (2022)

Are Sarcopenia and Myosteatosis in Elderly Patients with Pelvic Ring Injury Related to Mortality, Physical Functioning and Quality of Life?
por: Banierink, Hester, et al.
Publicado: (2021)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Sarcopenia and Myosteatosis Assessed by Magnetic Resonance Enterography May Predict Negative Outcomes in Patients with Crohn’s Disease
por: Eren Cankurtaran, Rasim, et al.
Publicado: (2023)

Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis
por: Mori, Katsuhito, et al.
Publicado: (2019)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

Myosteatosis predicting risk of transition to severe COVID-19 infection
por: Yi, Xiaoping, et al.
Publicado: (2022)

Low Parathyroid Hormone Versus Secondary Hyperparathyroidism and Survival in Patients Undergoing Hemodialysis: A Propensity-Matched Analysis
por: Guo, Wang, et al.
Publicado: (2022)

Abdominal obesity in Chinese patients undergoing hemodialysis and its association with all-cause mortality
por: Shi, Zhihua, et al.
Publicado: (2023)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
por: Cespiati, Annalisa, et al.
Publicado: (2022)

Risk Assessment of Sarcopenia in Patients With Type 2 Diabetes Mellitus Using Data Mining Methods
por: Cui, Mengzhao, et al.
Publicado: (2020)

The role of obesity in sarcopenia and the optimal body composition to prevent against sarcopenia and obesity
por: Liu, Chaoran, et al.
Publicado: (2023)

Association between body fat and sarcopenia in older adults with type 2 diabetes mellitus: A cross-sectional study
por: Sun, Lina, et al.
Publicado: (2023)

Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

Is sarcopenia a real risk factor for mortality in patients undergoing hemodialysis?
por: Bae, Eun Hui
Publicado: (2019)

Screening of osteoporosis and sarcopenia in individuals aged 50 years and older at different altitudes in Yunnan province: Protocol of a longitudinal cohort study
por: Liu, Xingli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8clpb4escbmdua5co3n0fpee2